Acquired haemoglobin S trait in an adult patient with secondary acute myelogenous leukaemia allografted with matched unrelated umbilical cord blood cells using a non-ablative conditioning regimen

HAEMA

Volumn 8, Issue 3, 2005, Pages 492-496

  Ruiz Argüelles, Guillermo J ^a,b,e   Núñez, Virginia Reyes ^b   Garces Eisele, Javier ^b   Warwick, Ruth M ^c   McKenna, Lisa ^c   Ruiz Reyes, Guillermo ^b   Granados, Julio ^d   Mercado Diaz, Miguel A ^d  

^a UNIVERSIDAD DE LAS AMÉRICAS PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c NHSBT   (United Kingdom)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

Author keywords

Acquired; Allograft; HbS; Leukemia; Non myeloablative; Umbilical cord blood transplantation

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; FLUDARABINE; HEMOGLOBIN S; ITRACONAZOLE; MELPHALAN; ONDANSETRON; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGRAFT; ARTICLE; CASE REPORT; CHIMERA; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; MALE; MICROSATELLITE MARKER; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; UMBILICAL CORD BLOOD;

EID: 23044449157     PISSN: 11082682     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gluckman E, Broxmeyer HA, Auerbach AD. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cotd blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-1178.
2. Berker JN, Wagner JE. Umbilical cord blood transplantation. Current state of the art. Curr Opin Oncol 2002; 14: 160-164.
3. Kernan NA, Bartsch G, Ash RC. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
4. Beatty PG, Clift RA, Mickelson EM. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765-771.
5. nd edition, Malden MA; Blackwell Science, 1999, pp. 503-512.
6. Koh LP, Chao NJ. Umbilical cord blood transplantation in adults using myeloablative and non-myeloablative preparative regimens. Biol Blood Marrow Transpl 2004; 10: 1-22.
7. Barker JN, Krepski TP, DeFor TE. Searching for unrelated dnor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow. Biol Bone Marrow Transpl 2002; 8: 257-260.
8. Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord transplantation. Rev Clin Exp Hematol 2001; 5: 87-89.
9. Rocha V, Wagner JE, Sobocinski KA. Graft versus host disease in children who have received a cord blood or bone marrow transplant from and HLA-identical sibling. N Engl J Med 2000; 342: 1846-1854.
10. Ruiz-Argüelles GJ, Gómez-Rangel D, Sánchez-Anzaldo J, Ruiz-Argüelles A, Porras-Ramírez G, Luis-López A. Trasplante de células de cordón umbilical: Informe de dos casos. Medicina Univ 2002; 4: 233-235.
11. Tsimberidou AM, Stavroyianni N, Viniou N et al. The Hellenic Cooperative Group. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with acute myelogenous leukemia. Cancer 2003; 97: 1721-1731.
12. Georges G, Storb R. Review of "minitransplantation": Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Int J Hematol 2003; 77: 3-14.
13. Djulbegovic B, Seidenfeld J, Bonnell C, Kumar A. Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: A systematic review. Cancer Control 2003; 10: 17-31.
14. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood 1998; 91: 756-763.
15. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531-4536.
16. Ruiz-Argüelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, González-Llano O, Cantú OG, Jaime-Pérez JC. Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens. Am J Hematol 2001; 66: 241-244.
17. Ruiz-Argüelles GJ, Gómez-Almaguer D, López- Martínez B, Cantú-Rodríguez OG, Jaime-Pérez JC, González-Llano O. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica 2002; 87: 894-896.
18. Ruiz-Argüelles GJ, Gómez-Almaguer D, Gómez Rancel JD et al. Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute leukemia eligible for conventional allografting: A prospective study. Leuk Lymphoma 2004; 45: 1191-1195.
19. Hall JG, Rice HE, Skinner MA, Szabolcs P, Kutzberg J. Splenectomy prior to umbilical cord blood transplantation facilitates hematologic engraftment in pediatric and adult patients. Blood 2003; 102(suppl.): 470a.
20. Ruiz-Argüelles GJ, López-Martínez B, Gómez-Rangel D et al. Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: A single institution experience Hematology 2003, 8: 151-154.
21. Lawler M, Mc Cann SR. Polymerase chain reaction based methods for assessing chimerism following bone marrow transplantation. In Cotter FE (ed): Molecular diagnosis of cancer. Humana Press Inc. Totowa, NJ. 1996, pp. 105-120.
22. Anker R, Steinbrueck T, Donis-Keller H. Tetranucleotide repeat polymorphism at the human thyroid peroxidase (hTPO) locus. Hum Mol Genet 1992; 1: 137.
23. Perez-Lezaun A, Calafell F, Mateu E, Comas D, Bosch E, Bertranpetit J. Allele frequencies for 20 microsatellites in a worldwide population survey. Hum Hered 1997; 47: 189-196.
24. Urquhart A, Oldroyd NJ, Kimpton CP, Gill P. Highly discriminating heptaplex short tandem repeat PCR system for forensic identification. Biotechniques 1995; 18: 116-118,120-121.
25. Jin L, Underhill PA, Buoncristiani M, Robertson JM. Defining microsatellite alleles by genotyping global indigenous human populations and non-human primates. J Forensic Sci 1997; 42: 496-499.
26. Kimpton CP, Gill P, Walton A, Urquhart A, Millikan ES, Adams M. Automated DNA profiling employing multiplex amplification of short tandem repeat loci. PCR Methods Appl 1993; 3: 13-22.
27. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
28. Rubinstein P, Taylor PE, Scaradavou A et al. Unrelated placental cord blood for bone marrow reconstitution organisation of the placental blood programme. Blood Cells 1994; 20: 587-600.
29. Long GD, Laughlin M, Madan B et al. Unrelated umbilical cord transplantation in adult patients. Biol Blood Marrow Transpl 2003; 9: 772-780.
30. Khee WHY, Chye PTH, Hoe TC, Fung HG, Khiang HK, Tee GY. Autologous recovery with protractedly undetectable donor chimerism can precede stable donor engraftment in a nonmyeloablative cord blood transplant. Int J Hematol 2003; 78: 73-75.
31. Walters MC, Patience M, Leisenring W et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transpl 2001; 7: 665-673.